Fortress Biotech, Inc. (FBIO)
2.93
+0.06
(+2.09%)
USD |
NASDAQ |
Aug 24, 16:00
2.93
0.00 (0.00%)
After-Hours: 20:00
Fortress Biotech Total Assets (Quarterly) : 316.72M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 316.72M |
| March 31, 2026 | 356.87M |
| December 31, 2025 | 185.55M |
| September 30, 2025 | 181.41M |
| June 30, 2025 | 159.90M |
| March 31, 2025 | 178.07M |
| December 31, 2024 | 144.22M |
| September 30, 2024 | 127.08M |
| June 30, 2024 | 145.68M |
| March 31, 2024 | 164.64M |
| December 31, 2023 | 167.53M |
| September 30, 2023 | 150.55M |
| June 30, 2023 | 180.72M |
| March 31, 2023 | 263.55M |
| December 31, 2022 | 294.30M |
| September 30, 2022 | 323.56M |
| June 30, 2022 | 363.96M |
| March 31, 2022 | 407.93M |
| December 31, 2021 | 396.50M |
| September 30, 2021 | 407.83M |
| June 30, 2021 | 418.16M |
| March 31, 2021 | 391.04M |
| December 31, 2020 | 333.41M |
| September 30, 2020 | 295.88M |
| June 30, 2020 | 268.57M |
| Date | Value |
|---|---|
| March 31, 2020 | 228.76M |
| December 31, 2019 | 226.42M |
| September 30, 2019 | 221.59M |
| June 30, 2019 | 227.26M |
| March 31, 2019 | 200.54M |
| December 31, 2018 | |
| September 30, 2018 | 224.92M |
| June 30, 2018 | 236.87M |
| March 31, 2018 | 265.08M |
| December 31, 2017 | 245.95M |
| September 30, 2017 | 245.09M |
| June 30, 2017 | 249.85M |
| March 31, 2017 | 211.91M |
| December 31, 2016 | 170.73M |
| September 30, 2016 | 145.42M |
| June 30, 2016 | 98.06M |
| March 31, 2016 | 104.91M |
| December 31, 2015 | 118.61M |
| September 30, 2015 | 86.86M |
| June 30, 2015 | 83.70M |
| March 31, 2015 | 90.45M |
| December 31, 2014 | 89.33M |
| September 30, 2014 | 88.01M |
| June 30, 2014 | 90.87M |
| March 31, 2014 | 94.90M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Inovio Pharmaceuticals, Inc. | 49.39M |
| Ironwood Pharmaceuticals, Inc. | 285.13M |
| Kura Oncology, Inc. | 587.79M |
| Spero Therapeutics, Inc. | 52.77M |
| Cue Biopharma, Inc. | 30.71M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 110.63M |
| Shareholders Equity (Quarterly) | 164.14M |
| Debt to Equity Ratio | 0.3248 |
| Current Ratio | 3.959 |
| Net Debt Paydown Yield | 4.10% |